Evidence map›Paper›PMID 30123057›Full record

ArticleInternational journal of medical sciences2018

Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice.

Chih-Hung Guo, Wen-Long Chen, Chung-Huei Liao, Karin Huang, Pei-Yin Chen, Chun-Pai Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chih-Hung GuoInstitute of Biomedical Nutrition, Hung-Kuang University, Taichung 433, Taiwan, ROC.
Wen-Long ChenBrain Genesis Biotechnology Co., Ltd., Taipei 112, Taiwan, ROC.
Chung-Huei LiaoBrain Genesis Biotechnology Co., Ltd., Taipei 112, Taiwan, ROC.
Karin HuangBrain Genesis Biotechnology Co., Ltd., Taipei 112, Taiwan, ROC.
Pei-Yin ChenDepartment of Recreation and Holistic Wellness, Ming-Dao University, Changhua 523, Taiwan, ROC.
Chun-Pai YangInstitute of Biomedical Nutrition, Hung-Kuang University, Taichung 433, Taiwan, ROC.
MingDao University · TWChina Medical University Hospital · TWKuang Tien General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drugs, Chinese HerbalInsulin ResistanceNon-alcoholic Fatty Liver DiseaseAnimalsCyclic Nucleotide Phosphodiesterases, Type 3Diet, High-FatLiverMaleMiceMice, Inbred C57BLTaiwanCyclic Nucleotide Phosphodiesterases, Type 3Drugs, Chinese HerbalBNG-1Hepatic steatosisInsulin resistanceNon-alcoholic fatty liver diseaseOxidative stressPhosphodiesterase (PDE)3B

Identifiers

PMID30123057
PMCPMC6097264
OpenAlexW2886147450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.